Subterranean clover in W.A. 1. The current situation

From small beginnings some 50 or more years ago subterranean clover has come to dominate the pasture scene in Western Australia. Of the 7 000 000 hectares of sown pasture all but some 500 000 are sown to subterranean clover. Further, it is estimated that there remains an area of similar size still to be sown, although in some instances these future sowings will be possible only if suitable varieties are available. Clearing and pasture development within the various agricultural regions of the State took place, as a rule, within quite clearly defined time intervals and the varieties selected for sowing were those thought to suit the soil and rainfall patterns and generally to be the best on the information available at the time. Thus history and climate have combined to produce the current situatio

The certified strains of subterranean clover : their origin, potential use and identification

SUBTERRANEAN CLOVER originated in the countries surrounding the Mediterranean Sea and in parts of Western Europe. Therefore it is not surprising that it grows well in the agricultural districts of Western Australia, for these regions have a typically Mediterranean climate with cool wet winters and hot dry summers

Registered cultivars of subterranean clover : their origin, identification and potential use in Western Australia.

The annual species subterranean clover (Trifolium subterraneum L.) is the most important pasture legume in Western Australia. In addition to providing nutrious feed for livestock, it is an important source of nitrogen for non-leguminous species in pastures for the State\u27s ceral crops.https://researchlibrary.agric.wa.gov.au/bulletins/1230/thumbnail.jp

Importance of adequate sample sizes in fatty acid intervention trials

Abstract not availableLisa N. Yelland, Maria Makrides, Andrew J. McPhee, Julie Quinlivan, Robert A. Gibso

Phenotype and genotype of 197 British patients with McArdle disease: An observational single-centre study

McArdle disease is caused by recessive mutations in PYGM gene. The condition is considered to cause a “pure” muscle phenotype with symptoms including exercise intolerance, inability to perform isometric activities, contracture, and acute rhabdomyolysis leading to acute renal failure. This is a retrospective observational study aiming to describe phenotypic and genotypic features of a large cohort of patients with McArdle disease between 2011 and 2019. Data relating to genotype and phenotype, including frequency of rhabdomyolysis, fixed muscle weakness, gout and comorbidities, inclusive of retinal disease (pattern retinal dystrophy) and thyroid disease, were collected. Data from 197 patients are presented. Seven previously unpublished PYGM mutations are described. Exercise intolerance (100%) and episodic rhabdomyolysis (75.6%) were the most common symptoms. Fixed muscle weakness was present in 82 (41.6%) subjects. Unexpectedly, ptosis was observed in 28 patients (14.2%). Hyperuricaemia was a common finding present in 88 subjects (44.7%), complicated by gout in 25% of cases. Thyroid dysfunction was described in 30 subjects (15.2%), and in 3 cases, papillary thyroid cancer was observed. Pattern retinal dystrophy was detected in 15 out of the 41 subjects that underwent an ophthalmic assessment (36.6%). In addition to fixed muscle weakness, ptosis was a relatively common finding. Surprisingly, dysfunction of thyroid and retinal abnormalities were relatively frequent comorbidities. Further studies are needed to better clarify this association, although our finding may have important implication for patient management

Clinical outcome of SARS-CoV-2 infection in 7 adults with Duchenne muscular dystrophy attending a specialist neuromuscular centre

Due to their frailty and cardiorespiratory compromise adults with DMD are considered extremely vulnerable and at high risk of severe infection should they contract COVID-19. We report 7 adults with DMD aged 17–26 years who tested positive on a nasopharyngeal PCR swab for SARS-CoV-2. Despite long term corticosteroid treatment, severe respiratory compromise requiring night-time ventilation and receiving treatment for moderate to severe cardiomyopathy, none of the patients developed moderate to severe symptoms; in fact two remained asymptomatic and two developed only anosmia and reduced sensation. The remaining three developed transient fever with or without sore throat, cough and runny nose. All recovered fully without complication and no patient required hospitalization

Viral load and antibody boosting following herpes zoster diagnosis

BACKGROUND: Acute varicella zoster virus (VZV) replication in shingles is accompanied by VZV antibody boosting. It is unclear whether persisting virus shedding affects antibody levels. OBJECTIVES: To investigate the relationship between VZV viral load and antibody titres in shingles patients during six months following diagnosis and assess whether VZV antibody titre could discriminate patients with recent shingles from healthy population controls. STUDY DESIGN: A prospective study of 63 patients with active zoster. Blood samples were collected at baseline, one, three and six months to measure VZV DNA and IgG antibody titre. We compared VZV antibody titres of zoster patients and 441 controls. RESULTS: In acute zoster, viral load was highest at baseline and declined gradually over the following six months. Mean antibody titres rose fourfold, peaking at one month and remaining above baseline levels throughout the study. Antibody levels at one, three and six months after zoster were moderately correlated with baseline but not subsequent viral load. Regarding use of antibody titres to identify recent shingles, to achieve 80% sensitivity, specificity would be 23.4%, 67.7%, 64.8% and 52.6%, at baseline, visit 2, 3 and 4 respectively, whilst to achieve 80% specificity, sensitivity would be 28.3%, 66.1%, 52.6%, 38.6%, at baseline, visit 2, 3 and 4 respectively. CONCLUSIONS: Clinical VZV reactivation boosted VZV antibody levels and the level of boosting was dependent upon baseline viral replication. While antibody titres could discriminate patients with shingles 1-6 months earlier from blood donor controls, there was a large trade-off between sensitivity and specificity

Can we identify women who initiate and then prematurely cease breastfeeding? An Australian multicentre cohort study

Background: Health authorities recommend 6 months of fully breastfeeding and continuation of breastfeeding for at least a year. Many women initiate breastfeeding in hospital but discontinue before the six-month period, and therefore do not optimise the public health benefits. The aim of this study was to determine whether these women could be identified at hospital discharge, to enable targeted interventions. Methods: A secondary analysis of women who intended to breastfeed and were enrolled in a large randomized trial was undertaken. Women were enrolled in the antenatal period and antenatal, delivery and six month postnatal questionnaires were completed. Univariate and multivariate analyses were undertaken to determine the variables associated with early cessation of breastfeeding within six months, compared to women who continued to breastfeed. Results: Of 2148 women who initiated breastfeeding in hospital, 877 continued to breastfed either partially (N = 262) or fully (N = 615) until six months postpartum and 1271 ceased breastfeeding early. Median breastfeeding duration in women who ceased early was 3+6 weeks (IQR 1+1 to 11+2 weeks). In multivariate analysis, factors that were significantly associated with early cessation of breastfeeding were maternal factors of lower education (less than 12 years of schooling, no completion of further education), smoking (pre-pregnancy or during pregnancy), and newborn factors of preterm birth and low birthweight (all p \u3c 0.01). These variables correctly identify 83% of women. Conclusion: We can identify women who initiate and then prematurely discontinue breastfeeding prior to hospital discharge. Evaluation of additional interventions to support longer duration of breastfeeding in women at risk of ceasing prematurely is needed

Subterranean clover in W.A. 2. Characteristics required for agronomic success

Development of subterranean clover varieties is a rapidly changing scene, particularly in terms of farmer acceptance, disease and persistency problems. This is only to be expected, because this is an agricultural plant of only some 50 to 70 years standing, whereas many other pasture plants have been in common use for thousands of years